BF Suma
Pharmaceuticals Inc. was recently certified with ISO 22716 – Cosmetics Good Manufacturing
Practices in the US. This is the first step in the ‘S100’ strategy (100% Skin
Care Satisfaction) for entering the cosmetics sector, and highlights the
company’s determination to have a global impact in the skincare sector. With
new, first-rate facilities, Bright Future can now utilize its industry-leading
expertise and technology to provide a large variety of skincare products, such
as lotions, creams, essences, toners and facial masks.
Emphasis on global quality standards is and
always has been a top priority for the company, hence BF Suma has aligned
in this important direction to exceed their customers’ expectations. Mike
Ma, Vice President of Manufacturing and Supply at Bright Future said: “We are extremely
proud of this new US GMP-standard production line which highlights the
company’s high manufacturing standards and drive for excellence across its
operations. This affirms Bright Future’s ambitious S100 Strategy, diversifying the
business based on the advantage of our pharmaceutical background, so as to seek
new points of growth in future development.”
ISO 22716:2007 is an international standard
for Good Manufacturing Practices (GMP) for the cosmetics industry. It provides
guidelines covering production, packaging, testing, storage and delivery for consistently
ensuring high-quality and reliably safe cosmetic products.
